Recent Articles from Investor Brand Network

Massimo Group (NASDAQ: MAMO) reported financial results for the fiscal year ended Dec. 31, 2025, highlighting a significant expansion in gross margin to approximately 37.5% from 29.7% in 2024, driven by product mix optimization and cost efficiencies. While revenue declined to $71.8 million as the company rebalanced dealer inventory and prioritized pricing discipline, Massimo maintained profitability with $1.5 million in net income and continued advancing operational initiatives aimed at supporting long-term, higher-margin growth.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) reported audited financial results for the year ended Dec. 31, 2025, highlighting revenue growth driven by initial smart cart deployments, including $3.6 million in Q4 revenue and $7.9 million for the full year. The company reported $72.5 million in working capital and continued executing its $20 million share repurchase program, with $3.5 million completed to date, as it transitions toward scaled deployments and broader geographic expansion.

As the week gets to the mid-point, spot gold has been trading in a tight range around $4,500 an ounce as a firmer dollar, elevated yields on Treasuries and a hawkish Fed exert a drag on prices of the precious metal.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

ParaZero Technologies (NASDAQ: PRZO) announced it has signed a framework agreement with a Tier-1 international company specializing in autonomous drone interception, including integration of its DefendAir Net Pod into the client’s new drone platform. The agreement includes a minimum purchase of 2,000 customized units and is expected to expand global deployment of ParaZero’s Counter-UAS solutions while enhancing drone interception capabilities.

Electric vehicle manufacturers are constantly seeking ways to boost how far their models can go on a single charge, and a French tire maker has just come up with new tires that they say can boost EV range.

Cybersecurity shares fell sharply on March 27 after reports surfaced that Anthropic is testing a new AI system with advanced cyber capabilities and possible security concerns.

BYD’s European sales figures for the opening of 2026 are unlike anything the Chinese automaker has posted before. Registrations across the bloc surged to roughly three times the volume recorded in the same period last year.

Linkers Industries Limited (NASDAQ: LNKS) announced its board has approved a 1-for-250 reverse share split of its Class A and Class B ordinary shares, with post-split trading set to begin April 6, 2026, under the same ticker and a new CUSIP. The move, intended to support continued Nasdaq listing compliance, will proportionally adjust outstanding shares, par value and warrants, while maintaining shareholder ownership percentages aside from fractional share rounding.

NanoViricides, Inc. (NYSE American: NNVC) announced that a Phase II clinical trial of its antiviral candidate NV-387 for the treatment of MPox is expected to begin soon in the Democratic Republic of Congo, with site preparation and staff training scheduled for early April 2026. The study, already approved by the DRC regulatory agency, will evaluate the safety and effectiveness of NV-387 against Clade I MPox, as the company advances regulatory development and seeks Orphan Drug Designation from the U.S. FDA.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Rail Vision (NASDAQ: RVSN) reported financial results for the second half and full year ended Dec. 31, 2025, citing revenue growth and continued operational progress as it expands its global footprint. The company advanced deployments with Israel Railways, secured follow-on orders in Latin America, expanded into Central America and launched a proof of concept in India, underscoring increasing adoption of its AI-powered railway safety and obstacle detection systems in a global rail market projected to reach $460 billion by the mid-2030s.

Safe Pro Group (NASDAQ: SPAI) announced it has received a contract modification to provide continued support for its AI Edge Processing solution under an existing subcontract with the U.S. Government, reinforcing ongoing deployment of its AI-enabled defense and situational awareness technologies. The award supports the company’s efforts to advance real-time data processing and threat detection capabilities in government-sponsored applications.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced it has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2025, outlining a year marked by leadership changes, clinical progress and strategic expansion. The company advanced development of its lead compound LB-100, expanded clinical trials with additional sites and increased enrollment, completed the acquisition of Liora Technologies Europe Ltd. to enhance its cancer treatment platform, and raised more than $11 million to strengthen its balance sheet, as it positions for continued growth and innovation in oncology.

Datavault AI (NASDAQ: DVLT) CEO Nate Bradley will present at a private investor roundtable on April 2, 2026, at The Mar-a-Lago Club in Palm Beach, Florida, marking his second invitation in two months amid growing institutional interest in the company’s data monetization, tokenization and AI-driven platform. The event builds on momentum from a February engagement where Datavault AI highlighted $49 million in fourth-quarter 2025 agreements and projected more than $30 million in fiscal 2025 revenue, as the company continues to position itself at the intersection of data ownership, verified credentialing and real-world asset tokenization.

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.

The United States Army has introduced new recruitment rules that expand eligibility, allowing older applicants to join. Under the updated policy, individuals up to 42 years old can now enlist in active duty, the Army Reserve, and the Army National Guard. This marks a notable shift from the previous age limit of 35.

Forward Industries (NASDAQ: FWDI), a Solana treasury company, recently finished its first full reporting period as the world’s largest Solana treasury. A recent article shares details from an announcement of the company’s fiscal first quarter 2026 operating and financial results, updates, milestones and future plans. “As of Dec. 31, 2025, Forward Industries has SOL holdings of over 6.9 million, and almost all of the company’s SOL is staked. (As of the end of 2025, the company has generated over 112,171 SOL in staking rewards.)…Since the company adopted the SOL treasury strategy, FWDI’s validator infrastructure has generated between 6.5% and 7.2% gross annual percentage yield before fees, which outperforms many peer validators.”

HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed Joseph Gunnar & Co.’s upgrade of the company from Hold to Buy and raising of its 12-month price target to $4 from $1, citing regulatory progress and the company’s transition toward commercialization. The piece reads, “‘We upgrade HeartBeam to a BUY and High-Risk rating with a raised price target of $4 (from $1), reflecting progress in cardiac risk detection,’ the February 2026 report states. The report highlights a significant turning point for the company following FDA clearance of its 12-lead ECG synthesis software in December 2025 for arrhythmia assessment, which resolved an earlier regulatory setback and allowed HeartBeam to transition to commercial-stage status.”

Frontieras North America will host a groundbreaking ceremony on Thursday, April 2, 2026, at 11:30 a.m. ET for its first commercial FASForm(TM) facility in Mason County, West Virginia, with a livestream broadcast from Point Pleasant allowing remote audiences to participate in the milestone event. The ceremony will feature remarks from company leadership and government officials and mark the launch of an estimated $850 million project expected to create approximately 300 full-time jobs and 2,000 construction roles as the company advances commercialization of its solid carbon fractionation technology.

U.S. Energy (NASDAQ: USEG) announced the pricing of an underwritten public offering of 8.8 million shares at $1.00 per share for gross proceeds of approximately $8.8 million, with closing expected March 10, 2026, subject to customary conditions. The company said it intends to use net proceeds to fund growth capital for its industrial gas development project, including processing plant and infrastructure, as well as to support ongoing operations, with Roth Capital Partners serving as sole book-running manager.

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, is in the unique position of holding the world’s only clinical-stage protein phosphatase 2A (“PP2A”) inhibitor, called LB-100.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

Datavault AI (NASDAQ: DVLT) announced the closing of a definitive agreement with Coppercore Inc. to digitize and tokenize copper resources through its proprietary blockchain platform, targeting the creation of $100 million or more in Coppercoin(TM) digital tokens. Each token will represent five pounds of in-ground copper with pricing linked to COMEX benchmarks, enabling fractional, liquid ownership for global investors, as the company positions the initiative to launch by the end of the second quarter and expand access to the growing copper market tied to AI infrastructure, electrification and energy transition demand.

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) acknowledged its partner Hastings Technology Metals, alongside Wyloo, for acquiring a fully permitted mixed rare earth chloride production facility in Thailand, a move expected to accelerate near-term processing of monazite feedstock and strengthen a Western-aligned rare earth supply chain. The company said the development supports ongoing discussions toward a long-term supply agreement tied to its Louisiana Strategic Metals Complex, as it works to integrate upstream supply with midstream processing and rare earth oxide production capabilities.

Telomir Pharmaceuticals (NASDAQ: TELO) announced the submission of an Investigational New Drug application to the FDA for Telomir-1 (Telomir-Zn) targeting advanced and metastatic triple-negative breast cancer, supported by preclinical efficacy and safety data demonstrating tumor growth reduction and favorable tolerability. Pending IND clearance, the company plans to initiate a Phase 1/2 clinical trial evaluating the oral therapy, with a focus on safety, dose optimization and early signs of antitumor activity, as it advances a novel epigenetic approach aimed at addressing significant unmet need in aggressive breast cancer.

Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.

NextPlat (NASDAQ: NXPL, NXPLW) reported full-year 2025 revenue of approximately $54.3 million, down 18% year over year, reflecting declines in healthcare prescription volumes partially offset by growth in e-commerce sales and higher-margin services. The company highlighted significant cost reductions, including a 50% decrease in operating expenses, improved balance sheet strength with $13.7 million in cash and no meaningful unsecured debt, and a strategic shift toward higher-margin healthcare services and expanding global e-commerce operations, positioning the business for anticipated growth and improved profitability in 2026.

Towards the end of last week, the price of copper dropped by over 1% to reach $5.43 per pound. Thus far, the red metal’s price has reduced by more than 16% from its January high. A recently conducted analysis shows that copper’s sharp price increase from last year was primarily driven more by investor activity than by underlying market fundamentals.

The war in Iran is exposing something the global energy conversation has consistently glossed over. Different countries are approaching the shift away from fossil fuels from entirely different positions, at entirely different speeds, and with entirely different consequences when disruption hits. The crisis has made those differences impossible to ignore.

Surging oil prices are reshaping buying decisions for millions of drivers, and Chinese electric vehicle manufacturers are positioned to benefit the most. Geopolitical instability across the Middle East has pushed crude oil to above $100 per barrel, unsettling fuel markets worldwide.

Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.

A team of scientists from Texas Children’s Hospital, University of Pittsburgh and Baylor College of Medicine has discovered the primary driver of a deadly pediatric brain cancer, PFA (posterior fossa type A) ependymoma. They identified male sex hormones called androgens as playing a key role in promoting PFA ependymoma growth.

The number of electric vehicles on the road is growing steadily, and this shift is beginning to affect more than just the environment. New research shows that increasing the use of electric vehicles, often called EVs, could help lower gasoline prices for everyone, including people who still drive fossil fuel-powered cars.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

Annovis Bio (NYSE: ANVS) announced the publication of an article in The Scientist detailing the discovery and development of its lead drug candidate buntanetap, as the company advances ongoing Phase 3 and extension studies in Alzheimer’s disease and Parkinson’s disease. The company said the article provides historical and scientific context for buntanetap’s progression, with current trials showing approximately 70% enrollment in early Alzheimer’s and 20% enrollment in Parkinson’s, underscoring its focus on advancing neurodegenerative therapies toward key clinical and regulatory milestones.

A strong and diversified pipeline is often the foundation of long-term success in the biotechnology sector, enabling companies to sustain innovation while advancing multiple therapeutic opportunities. Soligenix (NASDAQ: SNGX) is reinforcing that foundation as its investigational therapy SGX945 receives Promising Innovative Medicine designation in the United Kingdom, a development that highlights both the potential of the therapy and the growing strength of the company’s rare disease pipeline.

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced positive Phase 1 data for TNX-4800, a long-acting monoclonal antibody targeting Borrelia burgdorferi, demonstrating rapid absorption, sustained protective levels for at least four months and a favorable safety profile in healthy subjects. The company said the single-dose subcutaneous therapy could offer a preventative option for Lyme disease, with plans to initiate an adaptive Phase 2 field study in the first half of 2027, pending FDA clearance, to evaluate protection in individuals in endemic areas.

Beeline Holdings (NASDAQ: BLNE) reported fourth-quarter 2025 net revenue of $2.5 million, up 127% year over year, on origination volume of $84.7 million, a 44% increase, as the company continued improving loan economics with a 31% rise in average revenue per loan and an 18% reduction in cost per loan. The company also launched its BeelineEquity platform, closing initial blockchain-recorded transactions, while ending the year debt-free and positioning for scalable growth, with management highlighting progress toward cash flow break-even and a long-term goal of reaching a $100 million revenue run rate.

Soligenix (NASDAQ: SNGX) reported 2025 results highlighting progress across its rare disease pipeline, including advancing its Phase 3 FLASH2 trial of HyBryte(TM) for cutaneous T-cell lymphoma with interim analysis expected in Q2 2026 and top-line results anticipated in the second half of the year. The company also noted regulatory momentum with orphan drug designation for dusquetide in Behçet’s Disease, ongoing development of SGX302 and SGX945 programs and a year-end cash position of approximately $7.9 million, as it continues to pursue strategic options to support late-stage development.

Nutriband (NASDAQ: NTRB) announced it has selected a proposed worldwide brand name for its abuse-deterrent fentanyl transdermal system, with plans to submit the name and product labeling to the FDA and international regulators as well as file for trademark protection. The company said the product, developed using its AVERSA(TM) technology, could become the first abuse-deterrent fentanyl patch designed to reduce misuse and accidental exposure, targeting a potential peak annual U.S. market of $80 million to $200 million while addressing broader global pain management needs.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO) is an artificial intelligence-powered precision cardiovascular medicine company focused on making cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators.

Lantern Pharma (NASDAQ: LTRN) reported fourth-quarter and full-year 2025 operational highlights led by continued progress in its LP-300 Phase 2 HARMONIC trial, completion of targeted enrollment in Japan, planned protocol discussions with the FDA in mid-May 2026 and advancement of LP-184, LP-284 and STAR-001 across multiple oncology indications. The company said its AI-driven portfolio now targets an estimated annual market opportunity of more than $15 billion, while its RADR(R) platform and newly introduced withZeta.ai multi-agentic co-scientist platform are expanding commercial potential, with beta testing underway at more than 25 biotech companies, cancer research centers and biopharma consultants, as Lantern ended 2025 with approximately $10.1 million in cash, cash equivalents and marketable securities.

Federal prosecutors have charged four individuals accused of operating multiple illegal cannabis cultivation sites across the Las Vegas Valley, according to information obtained by the 8 News Now Investigators.

Battalion Oil (NYSE American: BATL) announced it entered into a definitive agreement to raise approximately $15 million through a private placement priced at $5.50 per share, including prefunded warrants, with a new institutional investor. The company expects net proceeds of about $14.1 million, with Roth Capital Partners acting as sole placement agent, and plans to use the funds for working capital and general corporate purposes, with closing anticipated on March 4, 2026, subject to customary conditions.

SEGG Media (NASDAQ: SEGG, LTRYW) announced the appointments of Daniel Bailey as chief commercial officer and Jack Clarke as chief strategy officer following its Veloce acquisition, as the company advances a 90-day plan focused on integration, execution, and monetization. The new executives bring experience scaling Veloce Media Group and driving global partnerships and revenue growth, with SEGG Media targeting near-term expansion through its digital assets, including Sports.com, Concerts.com, and TicketStub.com, while emphasizing operational efficiency and disciplined strategy to enhance shareholder value.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Datavault AI (NASDAQ: DVLT) issued a corrected press release providing additional clarity on its Mandela Dollar (MUSD) initiative, a proposed USD-pegged stablecoin being developed with Mandela Dlamini & Manaway L.L.C. and Unity Reserve Holdings L.L.C. to support financial inclusion through low-cost remittances, micro-lending, savings, and digital payments in underserved regions. Datavault AI will serve as the primary technology partner, delivering AI-powered tokenization, blockchain infrastructure, and secure data systems to support issuance, compliance, and transparency, while emphasizing that MUSD is not yet live and warning against unauthorized tokens, with planned features including a 1:1 dollar peg, proof-of-reserves, ultra-low transaction fees, and integration with digital wallets and decentralized finance platforms as part of a phased global rollout.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Z-Polymers announced a strategic investment from Kureha Corporation, made through its subsidiary Kureha America Inc. as part of Z-Polymers’ Series Seed financing, alongside a joint development agreement to accelerate commercialization of its Tullomer(TM) liquid crystal polymer platform. The collaboration combines Z-Polymers’ polymer design with Kureha’s global manufacturing and commercialization expertise to advance high-performance polymer fibers and additive manufacturing materials for industrial applications.

Cancer patients with healthier thymus glands show dramatically better responses to immunotherapy, cutting progression risks by roughly one-third and death risks by nearly half compared to those with weaker thymic function. New research leveraging artificial intelligence to evaluate chest scans challenges medical assumptions that dismissed this immune organ as irrelevant past childhood, revealing it may determine who benefits from modern cancer treatments that are dependent on robust immune systems.

OpenAI has announced that it is shutting down Sora, its artificial intelligence video creation tool, in a move that has surprised many users and industry watchers. The decision comes just months after the tool gained wide attention for its ability to create highly realistic and imaginative videos using simple prompts.

The market for platinum group metals has gained a dose of optimism as the transition to electric mobility slows down. The auto industry consumes up to half of all the platinum produced annually while 80-90% of palladium is used within the auto industry. Switching to EVs therefore removes a large share of the market for these metals and would depress demand.

The crypto market has gone through plenty of volatility in 2026 so far, and this is continuing due to ongoing geopolitical factors around the world. But with cryptocurrencies being down so far this year, investors are faced with an opportunity to get into a market that was much more expensive only a few short months ago. The long-term forces supporting the move to blockchain-based currencies in the future are still there, and show no signs of going away.

NextPlat (NASDAQ: NXPL, NXPLW) announced its board approved a 1-for-10 reverse stock split, effective at 12:01 a.m. ET on April 6, 2026, with trading on a split-adjusted basis beginning April 7 on the Nasdaq Capital Market under the existing ticker “NXPL.” The split will reduce outstanding shares from approximately 27.0 million to about 2.7 million, was previously authorized by stockholders, and is intended to help the company regain compliance with Nasdaq’s minimum bid price requirement while broadening investor interest.

Knightscope (NASDAQ: KSCP) reported full-year 2025 revenue of $11.3 million, up 5% year over year, driven by a 7% increase in service revenue to $8.0 million, while net loss widened to $33.8 million and operating expenses rose to $29.1 million. The company ended the year with $20.6 million in cash, nearly doubling from 2024, and said its recent acquisition of Event Risk positions it for expected triple-digit revenue growth in 2026 as it scales its “Hardware + Software + Humans” autonomous security platform.

AI Maverick Intel (OTC: AIMV) announced a non-binding letter of intent to acquire 100% of HEAL Access Canada Inc., a subsidiary of HEAL Group Holdings Inc., as the first transaction under its right of first refusal agreement with HEAL. The proposed deal includes 20 million exchangeable shares and a secured vendor take-back note of approximately $5 million, and is expected to provide AIMV with an initial operating platform within HEAL’s AI-enabled healthcare ecosystem as the parties work toward a definitive agreement by May 29, 2026, subject to customary conditions and approvals.

Ovarian clear cell carcinoma and metastatic colon cancer remain among the most challenging malignancies to treat, with limited effective therapies and poor patient outcomes driving the urgent need for new approaches. LIXTE Biotechnology Holdings (NASDAQ: LIXT) is dedicated to addressing that need through the continued development of its lead compound LB-100. Recent updates from the company highlight expanding clinical trial activity designed to evaluate the drug’s potential across these difficult-to-treat cancers.

American Fusion (OTC: AMFN) announced it obtained a default judgment from the Superior Court of Washington, King County, ordering the cancellation of 1,683,000,000 shares of common stock deemed improperly issued by prior management, with the court confirming the underlying transactions were never consummated and are void. The company said the action strengthens its capitalization structure ahead of its first quarterly filing as a fully reporting company following the February 2026 merger with Kepler Fusion Technologies, completing a series of governance milestones including a PCAOB audit, Form 10 filing, and corporate name and symbol change as it advances toward exchange listing and commercialization of its fusion platform.

A new initiative by the Centers for Medicare & Medicaid Services could soon allow some patients enrolled in government-backed health insurance programs to receive partial coverage for hemp-based products. The proposal would allow eligible participants to access up to $500 annually in qualifying CBD products, with initial phases possibly starting as early as April 1.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising.

American Fusion (OTC: AMFN) announced that the U.S. Securities and Exchange Commission will not review its Form 10-12G registration statement, which is expected to become effective on May 14, 2026, automatically subjecting the company to full Exchange Act reporting requirements. The company said its first Form 10-Q, reflecting the February 2026 merger and newly integrated technology assets, will provide enhanced transparency, while the milestone supports a potential OTCQB uplisting, Form 211 sponsorship and ongoing investment banking discussions aimed at capital formation and a possible national exchange listing.

Perpetuals.com (NASDAQ: PDC) announced that its CySEC-regulated multilateral trading facility has received approval to expand its MiFID II license to include reception, transmission and execution of client orders, enabling direct client access without intermediaries. The company said the approval makes it the first European crypto derivatives venue to combine a fully regulated MTF with execution and proprietary clearing in a single entity, offering passportable access across more than 30 countries with full investor protections, while advancing its vertically integrated trading platform and launching products such as its Barrier Futures supported by its BayesShield risk management system.

The first two weeks of fighting in Iran generated over 5 million tons of carbon dioxide, exceeding Iceland’s entire annual emissions, as experts race to quantify how modern warfare accelerates climate change. Calculating exact figures remains difficult, but initial assessments show military fuel consumption dwarfs other sources, with commercial aviation disruptions and long-term reconstruction adding climate damage that will persist for years.

Bitcoin rebounded earlier in the week, surging 3.1% to trade at $70,352 after slipping below $68,000 over the weekend. Other major digital assets also moved higher, with Ether, XRP, SOL, and Dogecoin posting gains ranging from 2% to 4%.

Researchers seeking new ways of fighting cancer using immunotherapy have discovered a “hidden brake” that had previously been unknown to scientists. This brake exists on immune cells and scales back their ability to combat cancer, and it acts without any influence from tumor cells.

As tech firms race to expand their data center footprint across the U.S., residents are uniting to fight back against such a build-out, citing the adverse effects that such projects have on the environment and their communities. Locals in Arizona have become particularly vocal in their opposition to the mushrooming data centers in their communities.

The conflict involving Iran is shaking global energy markets in a serious way, but it may also create a turning point for the future of transport. While the short-term effects are painful, especially due to rising fuel costs, the situation could strengthen the long-term growth of electric vehicles (EVs).

China’s growing influence in open-source AI is giving it a powerful edge, one that analysts say could reshape global competition even as the country faces limits on access to cutting-edge chips.

A new report shows that India is transforming the Rann of Kutch into what is set to become the world’s largest renewable energy hub. This great region is a huge salt marsh located in the Thar Desert. It is said to be one of the biggest salt deserts globally, spanning about 26,000km 2 .